Credit Suisse’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-160,294
| Closed | -$477K | – | 3884 |
|
|
2016
Q3 | $477K | Sell |
160,294
-69,273
| -30% | -$206K | ﹤0.01% | 3122 |
|
|
2016
Q2 | $341K | Sell |
229,567
-32,863
| -13% | -$48.8K | ﹤0.01% | 3339 |
|
|
2016
Q1 | $971K | Buy |
262,430
+71,817
| +38% | +$266K | ﹤0.01% | 2470 |
|
|
2015
Q4 | $1.93M | Sell |
190,613
-253,703
| -57% | -$2.56M | ﹤0.01% | 2124 |
|
|
2015
Q3 | $6.04M | Sell |
444,316
-240,761
| -35% | -$3.27M | 0.01% | 1330 |
|
|
2015
Q2 | $13M | Buy |
685,077
+600,607
| +711% | +$11.4M | 0.01% | 987 |
|
|
2015
Q1 | $2.21M | Sell |
84,470
-25,676
| -23% | -$672K | ﹤0.01% | 2075 |
|
|
2014
Q4 | $2.31M | Sell |
110,146
-164,638
| -60% | -$3.45M | ﹤0.01% | 2128 |
|
|
2014
Q3 | $9.17M | Buy |
274,784
+11,948
| +5% | +$399K | 0.01% | 1162 |
|
|
2014
Q2 | $8.44M | Buy |
262,836
+192,933
| +276% | +$6.19M | 0.01% | 1301 |
|
|
2014
Q1 | $3.23M | Buy |
69,903
+33,708
| +93% | +$1.56M | ﹤0.01% | 1864 |
|
|
2013
Q4 | $2.57M | Buy |
36,195
+8,792
| +32% | +$624K | ﹤0.01% | 2098 |
|
|
2013
Q3 | $2.35M | Sell |
27,403
-7,557
| -22% | -$648K | ﹤0.01% | 1923 |
|
|
2013
Q2 | $2.21M | Buy |
+34,960
| New | +$2.21M | ﹤0.01% | 1871 |
|